Verity Acquisition in a letter to the SEC today said it is withdrawing an offering of 17.5 million units initially registered with the regulator in October 2021.
The SPAC had planned to pursue prospective targets based in the United States in the healthcare sector with an enterprise value of between $400 million and $1 billion.
Verity is led by CEO and Director Bing Lin, who is a managing director of Protocol Asset Management Limited, an activism hedge fund manager based in Hong Kong.
The SPAC had applied for a Nasdaq listing with Maxim tapped as sole book-running manager. Read more.
